'Patent cliff' spurs hunt for late-stage targets (Dealscape

Large pharmaceutical firms will likely hunt for companies with compounds in late-stage development as they seek to replace more than $74 billion in total sales on products that will lose patent protection by 2012, according to a Deloitte & Touche LLP report issued Tuesday.

One of the more prominent compounds earmarked to lose patent exclusivity will be Pfizer Inc.'s anticholesterol drug, Lipitor, which will be open to generic competition beginning 2011.

This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence.

Dig deeper, with Pipeline.

609 company pages related to Pharmaceuticals
158 in-depth transaction records for Deloitte & Touche
116 articles related to Lipitor
64 in-depth transaction records for Pfizer
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Skadden Arps
Idearc Inc.
Deutsche Bank
Amusement parks
Deb Shops
Windstream Corp.
Concho Resources
Hanna Andersson
Tween Brands
Edward Bastian

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? 'Patent cliff' spurs hunt for late-stage targets Posted on October 27, 2009 9:30 PM Large pharmaceutical firms will likely hunt for companies with compounds in late-stage development as they seek to replace more than $74 billion in total sales on products that will lose patent protection by 2012, according to a Deloitte & Touche LLP report issued Tuesday. One of the more prominent compounds earmarked to lose patent exclusivity will be Pfizer Inc.'s anticholesterol drug, Lipitor, which will be open to generic competition beginning 2011. This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence. Dig deeper, with Pipeline. 609 company pages related to Pharmaceuticals 158 in-depth transaction records for Deloitte & Touche 116 articles related to Lipitor 64 in-depth transaction records for Pfizer 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Skadden Arps Idearc Inc. Deutsche Bank Amusement parks Deb Shops Windstream Corp. Concho Resources Hanna Andersson Tween Brands Edward Bastian		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.